Kenya's struggle with fake medicines has escalated from a health emergency to a major business, regulatory and financial crisis that endangers lives and undermines investor confidence.
With an estimated 30 percent of medicines in Africa believed to be counterfeit, Kenya's weak enforcement structures, fragmented supply chains and policy gaps are fuelling the growth of an underground drug economy.
